Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: A randomized open clinical trial

International Journal of Dermatology

Volumn 47, Issue 3, 2008, Pages 284-288

  Akhyani, Maryam ^a   Ehsani, Amir Houshang ^a   Ghiasi, Maryam ^a   Jafari, Alireza Keshtcar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; EPIGASTRIC BURNING; FEMALE; HUMAN; MALE; OPEN STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DIARRHEA; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEARTBURN; HUMANS; MALE; MIDDLE AGED; ROSACEA; SKIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 39449083744     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03445.x     Document Type: Article

References (22)

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002; 46: 584-587.
2. Del Rosso JQ. Systemic therapy for rosacea: Focus on oral antibiotic therapy and safety. Cutis 2000; 66: 7-15.
3. Plewig G, Jansen T. Rosacea. In: Freedberg IM, Eisen AZ, Wolff K, et. al., eds. Fitzpatrick's Dermatology in General Medicine, Vol. 1, 5th edn. New York: McGraw-Hill, 1999: 785-794.
4. Bakar O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004; 43: 151-154.
5. Alvarez-Elroco S, Enzler MJ. The macrolides: Erythromycin, clarithromycin, azithromycin. Mayo Clin Proc 1999; 74: 613-634.
6. Peters DH, Friedel HA, McTavish D. Azithromycin. A review of its antimicrobial, pharmacokinetic properties, and clinical efficacy. Drugs 1992; 44: 750-799.
7. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol 2000; 39: 45-50.
8. Gruber F, Grubisic-Greblo H, Kastelan M. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa. J Chemother 1998; 10: 469-473.
9. Bikowski JB. Treatment of rosacea with doxycycline monohydrate. Cutis 2000; 66: 149-152.
10. Sanchez J, Somolinos AL, Almodovar PI, et al. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablet and metronidazole 0.75% topical lotion in the treatment of rosacea. J Am Acad Dermatol 2005; 53: 791-797.
11. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol 2005; 30:215-220.
12. Powell FC. What's going on in rosacea? J Eur Acad Dermatol Venereol 2000; 14: 351-352.
13. Humbert P, Treffel P, Chapuis JF, et al. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691-697.
14. Bannatyne RM. Metronidazole, its bioactive metabolites and acne. Curr Med Res Opin 1999; 15: 298-299.
15. Labro MT. Anti-inflammatory activity of macrolides: A new therapeutic potential? J Antimicrob Chemother 1998; 418: 37-46.
16. Scaglione F, Rossini G. Comparative anti-inflammatory effects of roxithromycine, azithromycin and clarithromycin. J Antimicrob Chemother 1998; 41: 47-50.
17. McDonald PJ, Pruul H. Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 1991; 10: 828-833.
18. Voils SA, Evans ME, Lane MT, et.al. Use of macrolides and tetracyclines for chronic inflammatory diseases. Ann Pharmacother 2005; 39: 86-94.
19. Heikkinen T, Laine K, Neuvoneon PJ, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770-775.
20. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991; 91: 40S-45S.
21. Bergman M, Huikko S, Huovinen P, et al. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 2006; 50: 3646-3650.
22. Bergman M, Huikko S, Pihlajamäki P, et.al. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38: 1251-1256.